MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517058872 A) filed by Universitat De Barcelona; Fundacio De Recerca Clinic Barcelona-Institut D'Investigacions Biomediques August Pi I Sunyer; and Hospital Clinic De Barcelona, Barcelona, Spain, on June 19, for 'cd229 and bcma targeting moieties for the treatment of cd229- bcma- positive cancer.'
Inventor(s) include Engel Rocamora, Pablo; Rodriguez Lobato, Luis Gerardo; Fernandez De Larrea Rodriguez, Carlos Jose; and Cardus Granell, Oriol.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a CD229 and a BCMA target...